Ultragenyx Pharmaceutical
RARE
#5245
Rank
$1.70 B
Marketcap
$16.70
Share price
3.47%
Change (1 day)
-49.77%
Change (1 year)

Ultragenyx Pharmaceutical (RARE) Fails to deliver data

Key failure to deliver metrics for Ultragenyx Pharmaceutical:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Ultragenyx Pharmaceutical (RARE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Ultragenyx Pharmaceutical (RARE) - since 2014

Volume in USD (price x number of shares), data since 2014

Ultragenyx Pharmaceutical (RARE) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024$3.56 M-75.4%
2023$14.48 M344.12%
2022$3.26 M-64.77%
2021$9.26 M-20.49%
2020$11.64 M-3.02%
2019$12.01 M-75.7%
2018$49.42 M-12.01%
2017$56.16 M-14.47%
2016$65.66 M-56.5%
2015$0.15 B326.02%
2014$35.43 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Lexicon Pharmaceuticals
LXRX
$1.06 M$3.45 M๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
N/A$21.79 M๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
N/A$0.11 B๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$9.39 M$23.37 M๐Ÿ‡บ๐Ÿ‡ธ USA